What We're Reading: Page 150
Industry reads hand-picked by our editors
Jun 01, 2021
-
The Washington Post
Alzheimer’s drug sparks emotional battle as FDA nears deadline on whether to approve
-
Life Sci VC
Biotech’s Relevancy Challenge In An Expanding Universe
-
Reuters
Even after U.S. shift, opponents resist COVID-19 vaccine patent waiver
-
STAT
The name game for coronavirus variants just got a little easier
May 28, 2021
-
Science
Rich countries cornered COVID-19 vaccine doses. Four strategies to right a 'scandalous inequity'
-
Endpoints News
FDA adcomm votes in favor of approving Provention Bio's drug to delay type 1 diabetes
-
The Wall Street Journal
FDA, J&J Near Deal for Covid-19 Vaccine Production at Baltimore Plant
-
Evaluate Vantage
Bristol joins fast-growing ulcerative colitis market
May 27, 2021
May 26, 2021
-
The Wall Street Journal
Two College Pals Reunite After 50 Years in Race for Covid-19 Vaccines
-
Evaluate Vantage
Lilly leads the big pharma pack on pipeline value
-
STAT
Most clinical trials are still not reported on time to federal database
May 25, 2021
-
STAT
A gene therapy opens a new chapter for children, but challenges endure
-
Reuters
UK regulator reviewing AstraZeneca's $39 billion Alexion buyout
-
Science
I'm subject NL002-0060 and I'm dropping out of my COVID-19 vaccine trial
-
Endpoints News
AbbVie's last stand: How an Icelandic billionaire's biosimilar has one final shot to dethrone Humira
May 24, 2021
-
Endpoints News
Inside Vertex 3.0: Can Reshma Kewalramani repeat one of biotech's biggest success stories 'again and again and again'?
-
The New York Times
These Sisters With Sickle Cell Had Devastating, and Preventable, Strokes
-
The Sunday TImes
Ministers fear forced sale of GlaxoSmithKline
-
Reuters
U.S. CDC looking into heart inflammation in some young vaccine recipients
May 21, 2021
-
Fast Company
Tory Burch and Nobel Prize winner Jennifer Doudna are teaming up to help women scientists
-
In The Pipeline
CRISPR Editing in Primates
-
Chemical & Engineering News
To conquer COVID-19, create the perfect pill
-
Fierce Biotech
RenBio joins bigwigs Eli Lilly, Regeneron in hunt for next gen COVID-19 antibodies after $24M financing
Previous
